HOME >
Seminars in WASHINGTON >
Seattle >
Japan Regulatory Compliance Requirements for Life Science Products Japan Regulatory Compliance Requirements for Life Science Products Seminar
Presented by Global Compliance Panel
This 2-Day seminar covers the details of the Regulatory Requirements for a wide-range of Life Science products in Japan: Pharmaceuticals, Biologics, Medical Devices and Combination Products. The syllabus also covers the change in Japan caused by the re-write of the Pharmaceutical Affairs Law [PAL] into the Pharmaceuticals & Medical Device Law [PMDL] and the country's latest update to GMP requirements.
Course Description
Course "Japan Regulatory Compliance Requirements for Life Science Products" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.
Overview:
-
This 2-Day seminar covers the details of the Regulatory Requirements for a wide-range of Life Science products in Japan: Pharmaceuticals, Biologics, Medical Devices and Combination Products. The syllabus also covers the change in Japan caused by the re-write of the Pharmaceutical Affairs Law [PAL] into the Pharmaceuticals & Medical Device Law [PMDL] and the country's latest update to GMP requirements.
The information presented will help you gain a comprehensive understanding of the Regulatory Structure, Product Classification, Clinical Trial Requirements, Marketing Authorization Procedures, Variations Processing, License Renewals, GMP requirements and cultural working aspects within the Regulatory Environment in Japan. It will prepare you for regulatory approval processes, Agency meetings, the complexities of running clinical studies, the importance of partner selection and also add the cultural knowledge needed for success in-country. The recent changes made by PMDA to be more sponsor and applicant-friendly, along with the impact this has had on dossier review times, will be shared. Real world experiences on actual interactions with the Agency, since these changes have been implemented, will also be discussed.
Course Objective:
Attendees will leave this Course clearly understanding the Regulatory Procedures necessary to be successful in getting your products to market in a timely fashion. This Course has been updated to provide participants with competitive insight into:
- The impact of the PAL to PMDL Law change to applicants
- Who can legally register Life Science products in Japan
- If you want to be the legal License holder, what will you need: establishment office & personnel type
- When will additional clinical trials be needed on products and on which ones
- Will Japan accept global, clinically-developed data
- How does a Japanese CTD submission differ from ICH requirements
- What is required to register a Medical Device in Japan
- Japan's Medical Device classification procedures and regulatory pathways
- Can you expect a GMP inspection of your facility by PMDA staff; updates to GMP Regulation & Guidelines
- What are your post-marketing responsibilities as a License Holder
- How best to work with the Authorities from a Business and Cultural Aspect
Who will benefit:
This seminar will benefit Project Team Members, whose specific functional discipline comes from:
- Clinical Operations Staff
- Quality Assurance
- Monitors / CRAs
- Regulatory Affairs Personnel
- Pharmacovigilance Reporting personnel
- Global Supply Chain personnel
- Manufacturing personnel
- Global Business Development personnel
- Commercial Management
- Country Managers
- CRO's, Consultants
Agenda:
Day 1 Schedule
Part I: Japan Regulatory Compliance
Lecture 1:
Japan's Regulatory Structure for the Life Science Product Industries
- Country Healthcare System
- Regulatory Framework: Key Agencies Involved / Reporting Structure
- MHLW (Ministry of Health, Labor and Welfare)
- PMDA (Pharmaceutical and Medical Device Agency)
- Agency Consulting Committees
- Patent System
- Pharmaceutical Affairs Law (PAL) → Pharmaceuticals & Medical Device Law (PMDL)
Lecture 2:
Beginning Your Company Involvement in Japan
- Local Office and Personnel Requirements
- Language Requirements & Translations
- License Types
- Options for Importers / Overseas Manufacturers
Lecture 3:
Objectives of the Rules Governing Medicinal Procedures
Life Science Regulations and the Regulatory Processes in Japan
- Conducting Clinical Trials
- New Product Registrations
- Handling of Risk Management
- Post-Marketing Requirements: Variations / amendments, Safety Reporting, Renewals
Lecture 4:
Japan's Use of ICH Standards / Principles
- GCP
- GMP
- CTD / e-CTD Submissions
Lecture 5:
Starting-Up and Conducting Clinical Trials
- Who can conduct Clinical Trials?
- When are they needed?
- Start-up Process & Timelines
Day 2 Schedule
Part II:
Lecture 1:
Marketing Authorization Processes - Product Registrations / Licensing
- Drugs
- Medical Devices
- Biologics
- Combination Products
- Drug / Device Master File (DMF) Use in Japan
- Labeling Requirements
- Packaging Information Leaflets
Lecture 2:
Variations: Changes to Marketed Products
- Types of Variations & Dossier Maintenance Expectations
Lecture 3:
License Renewals
- Process and timing for Renewing Licenses
Lecture 4:
Comparing and Contrasting Japan's Procedures vs. U.S. FDA
- Comparison of Processes
- Expected Timelines
Lecture 5:
How and When to Influence the Regulatory Process
- The Do's and Don'ts of Regulatory Involvement in Japan
- Utilizing Local Regulatory Resources
Speaker:
Robert Russell
President / CEO , RJR Consulting, Inc.
Robert J. Russell (Bob) is President / CEO of RJR Consulting, Inc. which specializes in helping clients navigate through Global Regulatory Compliance requirements for Pharmaceuticals, Medical Devices, Biologics, Combination Products and Dietary Supplement / OTC products. Prior to founding the company 17 years ago, Bob had more than 27 years of experience in CMC, Global Business development and Regulatory Affairs for two Fortune 200 firms developing innovative Pharmaceuticals and Medical Devices.
Credits AvailableCourse "Japan Regulatory Compliance Requirements for Life Science Products" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.
More Seminar Information |
Global Compliance Panel
|
Summary |
This 2-Day seminar covers the details of the Regulatory Requirements for a wide-range of Life Science products in Japan: Pharmaceuticals, Biologics, Medical Devices and Combination Products. The syllabus also covers the change in Japan caused by the re-write of the Pharmaceutical Affairs Law [PAL] into the Pharmaceuticals & Medical Device Law [PMDL] and the country's latest update to GMP requirements. |
Delivery Method |
Seminar |
Who Should Attend |
Clinical Operations Staff, Quality Assurance, Monitors / CRAs, Regulatory Affairs Personnel, Pharmacovigilance Reporting personnel, Global Supply Chain personnelManufacturing personnel, Global Business Development personnel, Commercial Management, Country Managers, CRO's, Consultants |
|
|
Search similar training
Email this page
Print this document
Frequently Asked
Questions
Payment Options
Bill Me/Invoice
Credit Card
Register
Online
Fax Form
Availability
Seats currently available. Book now before the class is
full.
Other Information
Seminar |
|